Pediatric anesthesia & critical care

The Association of Guideline-Directed Prophylaxis with Postoperative Nausea and Vomiting in Pediatric Patients: A Single-Center, Retrospective Cohort Study

Anesth AnalgPublished Retrospective cohort study

Authors' conclusion

Guideline-directed PONV prophylaxis is inconsistently associated with incidence of PONV across the guideline-defined risk spectrum.

Study context

Population
Pediatric general anesthetic cases, 2018 to 2021
Participants
14,747 cases
Exposure
Adequate vs inadequate guideline-directed postoperative nausea and vomiting (PONV) prophylaxis
Outcome
PONV (documented postoperative nausea/emesis or rescue antiemetic)
Methodological detailssingle-centre, propensity score weighting, Bayesian binomial models
  • Single-centre
  • Propensity score weighting
  • Bayesian binomial models

Main finding

As reported in the abstract

Adequate prophylaxis vs InadequateWeighted median odds ratio (95% CrI)
Probability of benefit, 0.97
0.82(0.66–1.02)
Adequate prophylaxis
weighted marginal absolute risk reduction 1.3% (95% CrI −0.1% to 3.1%)

Observational data: associations, not effects.

Further findings

PONV by sum of risk factors (subgroup), unweighted

Reduced incidence with 1 to 2 risk factors, probability of benefit
0.96 and 0.95
Increased incidence with 3, 4, and 5 risk factors, probability of benefit
0, 0.01, and 0.03
  • Interaction between sum of risk factors and association of adequate prophylaxis with PONV

PONV by sum of risk factors (subgroup), weighted

Persistent benefit with 1 to 2 risk factors, probability of benefit
0.90 and 0.94
Equalization of risk with 3+ risk factors

Original publication

The Association of Guideline-Directed Prophylaxis with Postoperative Nausea and Vomiting in Pediatric Patients: A Single-Center, Retrospective Cohort Study. Anesth Analg. Published 17 June 2024. doi:10.1213/ane.0000000000006543

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.